JAN Biotech, Inc.
Ithaca, NY Doing business as JBI
- UEI
- DKDUTDKCJQE6
- CAGE
- 71ZJ8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 95 Brown Rd #279, Ithaca, NY 14850, USA
- Website
- janbiotech.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Clinical assay to accurately profile and monitor the HIV-1 reservoir in chronic-treated individuals to guide treatment… | National Institute of Allergy and Infectious Diseases | $300,000 | |
| DHA sbir direct phase II H2D-0219 sample collection and processing methods to support battlefield wound infection… | Defense Health Agency | $3,000,000 | |
| Pediatric latent HIV reservoir characterization and quantification assay - project summary abstract public health… | National Institute of Allergy and Infectious Diseases | $300,000 | |
| Rapid covid-19 mutation discrimination test for global sars-COV-2 variant surveillance | Office of Financial Resources | $827,298 | |
| Sequence-based RNA fluorescence assay to measure latent HIV reservoirs | National Institute of Allergy and Infectious Diseases | $8,290,037 |
About JAN Biotech, Inc.
JAN Biotech, Inc. (JBI) is a woman-owned small business based in Ithaca, New York, specializing in molecular diagnostic development and research focused on infectious disease technologies. The company primarily provides advanced research and development services to federal agencies, with a particular emphasis on diagnostic technologies for HIV and COVID-19. JBI operates as a for-profit corporate entity registered in SAM.gov, demonstrating its capability to engage in federal government contracting and grant work.
In terms of federal contract work, JBI has secured a significant Firm Fixed Price contract with the Defense Health Agency (DHA) under the Small Business Innovation Research (SBIR) program. This $2,999,999.66 contract, awarded in September 2024, focuses on developing sample collection and processing methods for battlefield wound infection diagnostics. The contract is designated as a total small business set-aside and will run until January 2027, highlighting JBI's capabilities in developing specialized medical research technologies for defense-related healthcare applications.
JBI has been awarded multiple federal grants predominantly from the National Institute of Allergy and Infectious Diseases (NIAID) and the Office of the Director. These grants have supported critical research in HIV and COVID-19 diagnostics, including developing advanced RNA-based testing technologies. Specific grant projects include a pediatric HIV reservoir characterization assay (R43AI179304), a COVID-19 mutation discrimination test for global SARS-CoV-2 variant surveillance (R43GH002389), and a sequence-based RNA fluorescence assay to measure latent HIV reservoirs (R44AI155075). These grants demonstrate JBI's expertise in developing innovative diagnostic technologies with potential global public health implications, particularly in understanding and tracking infectious diseases.
SBA capabilities narrative
Jan Biotech, Inc. capabilities include molecular diagnostics assay and detection instrumentation R&D for highly sensitive and quantitative nucleic acid (RNA, DNA) detection, including for latent HIV and sepsis pathogen/antibiotic resistance. Other capabilities include molecular biology and genetics R&D and services, microbial and viral sterilization testing.
Quick answers
What is JAN Biotech, Inc.'s UEI?
JAN Biotech, Inc.'s Unique Entity ID (UEI) in SAM.gov is DKDUTDKCJQE6.
What is JAN Biotech, Inc.'s CAGE code?
JAN Biotech, Inc.'s CAGE code is 71ZJ8.
What is JAN Biotech, Inc.'s primary NAICS code?
JAN Biotech, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is JAN Biotech, Inc. located?
JAN Biotech, Inc.'s physical address in SAM.gov is 95 Brown Rd #279, Ithaca, NY 14850, USA.
Is JAN Biotech, Inc. registered in SAM.gov?
Yes. JAN Biotech, Inc.'s SAM.gov registration is active through August 6, 2027.
What is JAN Biotech, Inc.'s most recent federal award?
JAN Biotech, Inc.'s most recent federal grant award is Clinical assay to accurately profile and monitor the HIV-1 reservoir in chronic-treated individuals to guide treatment… (R44AI195231), from National Institute of Allergy and Infectious Diseases, on August 1, 2026.
On GovTribe
See JAN Biotech, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors